Long-term Outcome of a Moderate-Hypofractionated Intensity Modulated Radiation Therapy (IMRT) Approach Utilizing an Endorectal Balloon for Patients with Localized Prostate Cancer

被引：2
|
作者：
Mai, W. [1 ]
Blanco, A.
Smiedala, M.
Paulino, A. C. [2 ]
Ishiyama, H. [2 ]
Xu, B. [2 ]
Butler, E. [2 ]
Teh, B. S. [2 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Methodist Hosp, Res Inst, Houston, TX 77030 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2010年 / 78卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2010.07.171
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S59 / S59
页数：1
相关论文
共 50 条
  • [1] Long-term outcome of a moderate-hypofractionated intensity modulated radiation therapy (IMRT) (77GY at 2.2GY per fraction) approach utilizing immobilization rectal balloon for localized prostate cancer
    Teh, B. S.
    Mai, W.
    McGary, J.
    Smiedala, M.
    Paulino, A. C.
    Grant, W.
    Butler, E. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S335 - S335
  • [2] Long-Term Outcome of Dose Escalated Hypofractionated Intensity Modulated Radiation Therapy (IMRT) for Localized Prostate Cancer
    Huang, R. Y.
    Vesprini, D.
    Bayley, A. J.
    Bristow, R. G.
    Chung, P.
    Gospodarowicz, M. K.
    Menard, C.
    Milosevic, M.
    Warde, P. R.
    Catton, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S421 - S422
  • [3] Long-term outcome of a moderately hypofractionated, intensity-modulated radiotherapy approach using an endorectal balloon for patients with localized prostate cancer
    Teh, Bin S.
    Lewis, Gary D.
    Mai, Weiyuan
    Pino, Ramiro
    Ishiyama, Hiromichi
    Butler, Edward Brian
    CANCER COMMUNICATIONS, 2018, 38
  • [4] Long-Term Outcomes of a Phase 2 Trial of Moderate Hypofractionated Image Guided Intensity Modulated Radiation Therapy (IG-IMRT) for Localized Prostate Cancer
    Lieng, H.
    Pintilie, M.
    Berlin, A.
    Bayley, A.
    Bristow, R. G.
    Chung, P.
    Gospodarowicz, M. K.
    Menard, C.
    Warde, P. R.
    Catton, C. N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S32 - S33
  • [5] LONG-TERM OUTCOME AND MORBIDITY AFTER TREATMENT WITH MODERATE HYPOFRACTIONATED RADIOTHERAPY AND ENDORECTAL BALLOON FOR PROSTATE CANCER
    Rutten, H.
    McColl, G.
    van Koltenburg, P.
    van Lin, E.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S409 - S410
  • [6] Tolerance of endorectal balloon in 396 patients treated with intensity-modulated radiation therapy (IMRT) for prostate cancer
    Bastasch, MD
    Teh, BS
    Mai, WY
    McGary, JE
    Grant, WH
    Butler, EB
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (01): : 8 - 11
  • [7] Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer
    Zelefsky, Michael J.
    Chan, Heather
    Hunt, Margie
    Yamada, Yoshiya
    Shippy, Alison M.
    Amols, Howard
    JOURNAL OF UROLOGY, 2006, 176 (04): : 1415 - 1419
  • [8] Long-term clinical and toxicity outcomes of hypofractionated intensity-modulated radiation therapy for clinically localized prostate cancer
    Kotecha, Rupesh
    Weller, Michael A.
    Marwaha, Gaurav
    Hearn, Jason
    Kupelian, Patrick
    Reddy, Chandana A.
    Ciezki, Jay P.
    Stephans, Kevin L.
    Tendulkar, Rahul D.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [9] Long-term outcome and morbidity after treatment with moderate hypofractionated radiotherapy, gold markers and endorectal balloon for prostate cancer
    van Lin, E.
    Mccoll, G.
    van Kollenburg, P.
    Hoffmann, A.
    Smeenk, R. J.
    Kaanders, J.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 45 - 45
  • [10] Long-Term Outcomes of a Prospective Study on Highly Hypofractionated Intensity Modulated Radiation Therapy for Localized Prostate Cancer for 3 Weeks
    Nakamura, Kiyonao
    Ikeda, Itaru
    Inokuchi, Haruo
    Aizawa, Rihito
    Ogata, Takashi
    Akamatsu, Shusuke
    Kobayashi, Takashi
    Mizowaki, Takashi
    PRACTICAL RADIATION ONCOLOGY, 2023, 13 (06) : E530 - E537
12345